NASOPHARYNX CANCER
Clinical trials for NASOPHARYNX CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNX CANCER trials appear
Sign up with your email to follow new studies for NASOPHARYNX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial targets Tough-to-Treat throat cancer
Disease control CompletedThis study tested a new combination of chemotherapy drugs (nab-paclitaxel, cisplatin, and fluorouracil) given before standard radiation and chemo in patients with advanced nasopharyngeal cancer. The goal was to see if this new drug sequence was safe and could shrink tumors more e…
Matched conditions: NASOPHARYNX CANCER
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug duo tested for Tough-to-Treat head and neck cancers
Disease control CompletedThis study tested whether combining two existing cancer drugs, pembrolizumab and cetuximab, could help control advanced head and neck cancer that had returned or spread. It involved 78 patients at four US cancer centers, grouped based on their prior treatments. The main goal was …
Matched conditions: NASOPHARYNX CANCER
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC